Steve Johnson

Steve Johnson has extensive experience in investment management and leadership roles within the technology and medical sectors. Currently serving as an Investment Manager at SCRA: South Carolina Research Authority since October 2017, Steve Johnson supports early-stage technology companies through investments and mentorship. Concurrently, as President and CEO of Brookhaven Vascular Inc. since April 2007, Steve Johnson is focused on developing innovative solutions for complications related to End Stage Renal Disease, with the Hemoaccess Valve System nearing final clinical testing. Previous positions include Director of Technology Management and Intellectual Property at Concurrent Technologies Corporation, President of Creative Technologies, and Vice President of New Product Development at Dow Chemical Company. Steve Johnson holds a degree from Furman University.